Athersys (ATHX) Misses Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. SPY
5. INTC
6. META
7. JBLU
8. ANT
9. NVDA
10. AAPL

Go back to Athersys (ATHX) Misses Q2 EPS by 2c

Athersys Reports Second Quarter 2020 Results

August 10, 2020 4:00 PM EDT

Management to host conference call at 4:30 pm EDT today

CLEVELAND--(BUSINESS WIRE)-- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended June 30, 2020.

Highlights of the second quarter of 2020 and recent events include:

Initiated and advanced enrollment in the Phase 2/3 COVID-19 induced acute respiratory distress syndrome (ARDS) clinical trial (the MACOVIA study) and currently evaluating the safety, tolerability and dose levels of MultiStem® cell therapy in this indication; Continued interactions with the Biomedical Advanced Research and Development Authority... More